Solid salt forms of a pyrrole substituted 2-indolinone

Details for Australian Patent Application No. 2006293644 (hide)

Owner Pfizer Products Inc.

Inventors Hawley, Michael; Sun, Changquan Calvin

Agent Shelston IP

Pub. Number AU-B-2006293644

PCT Pub. Number WO2007/034272

Priority 60/718,586 19.09.05 US

Filing date 8 September 2006

Wipo publication date 29 March 2007

Acceptance publication date 31 May 2012

International Classifications

C07D 403/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/404 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

20 March 2008 PCT application entered the National Phase

  PCT publication WO2007/034272 Priority application(s): WO2007/034272

31 May 2012 Application Accepted

  Published as AU-B-2006293644

27 September 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006293659-Chemo-immunotherapy method

2006293637-Amino-alkyl-amide derivatives as CCR3 receptor ligands